First Outpatient Evaluation of a Tubeless Automated Insulin Delivery System with Customizable Glucose Targets in Children and Adults with Type 1 Diabetes

Background: The objective of this study was to assess the safety and effectiveness of the first commercial configuration of a tubeless automated insulin delivery system, Omnipod(®) 5, in children (6–13.9 years) and adults (14–70 years) with type 1 diabetes (T1D) in an outpatient setting. Materials a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetes Technol Ther
Main Authors: Forlenza, Gregory P., Buckingham, Bruce A., Brown, Sue A., Bode, Bruce W., Levy, Carol J., Criego, Amy B., Wadwa, R. Paul, Cobry, Erin C., Slover, Robert J., Messer, Laurel H., Berget, Cari, McCoy, Susan, Ekhlaspour, Laya, Kingman, Ryan S., Voelmle, Mary K., Boyd, Jennifer, O'Malley, Grenye, Grieme, Aimee, Kivilaid, Kaisa, Kleve, Krista, Dumais, Bonnie, Vienneau, Todd, Huyett, Lauren M., Lee, Joon Bok, O'Connor, Jason, Benjamin, Eric, Ly, Trang T.
Formato: Artigo
Idioma:Inglês
Publicado em: Mary Ann Liebert, Inc., publishers 2021
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8215410/
https://ncbi.nlm.nih.gov/pubmed/33325779
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/dia.2020.0546
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados